PetMed Express, Inc. (PETS) News
Follow PetMed Express, Inc. (PETS) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 13 public stories across 11 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
PetMed names Jeffrey Allen Willard as CEO with equity grants under amended plan
PetMed appointed Jeffrey Allen Willard as Chief Executive Officer, effective September 28, 2026, with an equity award grant under an amended inducement plan.Original SEC Filing: PETMED EXPRESS INC [ PETS ] - 8-K - Sep. 2
REGULATION | Sep 28, 2026, 08:36 PM UTC
L
PetMed Express Price Target Cut to $1.40/Share From $2.15 by Morgan Stanley
Ratings actions from Benzinga: GMT) PetMed Express Is Maintained at Underweight by Morgan StanleyRatings actions from Benzinga
NEWS | Sep 25, 2026, 05:01 PM UTC
L
PETS - PetMeds Enhances Board of Directors with Appointment of Tamar Elkeles as New Independent Director
PETS - PetMeds Enhances Board of Directors with Appointment of Tamar Elkeles as New Independent Director
NEWS | Sep 21, 2026, 12:30 PM UTC
L
PETS - PetMeds Appoints Jeff Willard as CEO & President and Announces Board Leadership Transition
PETS - PetMeds Appoints Jeff Willard as CEO & President and Announces Board Leadership Transition
NEWS | Sep 17, 2026, 12:31 PM UTC
L
PETS - PetMeds Appoints Andrew Parry as Chief Technology Officer
PETS - PetMeds Appoints Andrew Parry as Chief Technology Officer
NEWS | Sep 14, 2026, 08:05 PM UTC
L
Shore Capital starts Pets at Home with ‘buy’ rating
Shore Capital has started Pets at Home at a ‘buy’, citing stabilising retail demand after the pandemic pet-ownership boom while noting weaknesses in accessories and execution around range, pricing and availability.
EQUITY | Sep 03, 2026, 02:51 PM UTC
L
REG - Pets at Home Grp - Holding(s) in Company
REG - Pets at Home Grp - Holding(s) in Company
EQUITY | Sep 01, 2026, 06:01 AM UTC
L
PetMeds (PETS) reports first-quarter financial results
PetMeds® announces its first quarter financial results, as reported by the TradeXchange Newsdesk.
EARNINGS | Aug 13, 2026, 08:07 PM UTC
L
PETS - PetMed Express, Inc. to Report First Quarter Fiscal Year 2027 Financial Results on Thursday, August 13, 2026
PETS - PetMed Express, Inc. to Report First Quarter Fiscal Year 2027 Financial Results on Thursday, August 13, 2026
EARNINGS | Jul 30, 2026, 12:02 PM UTC
L
PetMed Express shares are trading higher. The company confirmed its Board has received an unsolicited, non-binding, and conditional acquisit
PetMed Express shares are trading higher. The company confirmed its Board has received an unsolicited, non-binding, and conditional acquisition proposal from SilverCape for $3.00 per share in cash.
MNA | Jun 30, 2026, 05:33 PM UTC
L
PetMed Express Board Confirms Proposed $3/Share Acquisition Offer From SilverCape Investments
PetMed Express, Inc. ("PetMeds" or the "Company") (NASDAQ: PETS ) today confirmed that its Board of Directors (the "Board") has received an unsolicited, non-binding, and conditional proposal from SilverCape Investments L
MNA | Jun 30, 2026, 01:16 PM UTC
M
Activist Investor Slams PetMed Board For 'Stunning Destruction' Of Shareholder Value
PetMed Express, Inc. (NASDAQ: PETS ) stock is trading higher on Monday following the public release of a revised acquisition proposal from SilverCape Investments Limited. Revised Acquisition Proposal Details For PetMed E
MNA | Jun 29, 2026, 04:23 PM UTC
M
SilverCape Investments Revises Acquisition Proposal For PetMed Express To $3.00 Per Share In Cash With No Financing Contingency; Seeks PETS
The proposed purchase price represents a premium of approximately 70% to PetMed’s closing share price of $1.76 on June 26, 2026. In its letter to the Board, SilverCape outlines its belief that: Based upon the dismal quar
MNA | Jun 29, 2026, 11:12 AM UTC